![Dr. Husseini Manji image](/-/media/Project/PhRMA/Innovation-Org/Import/2018-06/i/Image1_RPTRDHM.jpg?h=286&w=286&hash=85A1293D7F400254F4FF1C8D200E5F3A)
Today, Dr. Husseini Manji is the global therapeutic head for neuroscience at Janssen. In this role, he has researched the ways in which psychiatric disorders alter a patient’s cellular systems, resulting in symptoms or negative behaviors. He has worked to change the way neuropsychiatric diseases are perceived and treated, shifting research away from strictly analyzing chemicals to a more holistic approach that looks at a person’s unique genetic makeup. His work has helped to conceptualize neuropsychiatric illnesses as genetically-influenced disorders, and it has led to the investigation of novel therapeutics for patients who have not responded to previous treatment.